Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMOOTH: Adalimumab De-escalation in Non-infectious Chronic Uveitis
NCT06390436Phase 4Not yet recruiting
- Sponsor
- CHU Saint-Etienne
- Start
- Dec 2026
- Primary completion
- Dec 2029
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in chronic non-infectious uveitis, sponsored by CHU Saint-Etienne. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
03
Conditions
chronic non-infectious uveitis
Beyond the preview
Go deeper on NCT06390436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06390436.